Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.7K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

8.2K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.2K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

298
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
298
Protein Networks02:26

Protein Networks

3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NeuroCL: A deep learning approach for identifying neuropeptides based on contrastive learning.

Analytical biochemistry·2025
Same author

Classification of Acid and Alkaline Enzymes Based on Normalized Van der Waals Volume Features.

Proteomics. Clinical applications·2025
Same author

GCNLA: Inferring Cell-Cell Interactions From Spatial Transcriptomics With Long Short-Term Memory and Graph Convolutional Networks.

IEEE journal of biomedical and health informatics·2025
Same author

Benchmarking of methods that identify alternative polyadenylation events in single-/multiple-polyadenylation site genes.

NAR genomics and bioinformatics·2025
Same author

Interpretable multi-instance heterogeneous graph network learning modelling CircRNA-drug sensitivity association prediction.

BMC biology·2025
Same author

Identifying the DNA methylation preference of transcription factors using ProtBERT and SVM.

PLoS computational biology·2025

Related Experiment Video

Updated: May 24, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.4K

DSANIB: Drug-Target Interaction Predictions With Dual-View Synergistic Attention Network and Information Bottleneck

Zhen Tian, Zhuangzhuang Zhang, Wanning Zhou

    IEEE Journal of Biomedical and Health Informatics
    |March 3, 2025
    PubMed
    Summary

    Predicting drug-target interactions (DTIs) is vital for drug repositioning. Our novel DSANIB model effectively captures local interactions and filters redundant information, outperforming existing methods for accurate DTI prediction.

    More Related Videos

    A Dual Task Procedure Combined with Rapid Serial Visual Presentation to Test Attentional Blink for Nontargets
    08:45

    A Dual Task Procedure Combined with Rapid Serial Visual Presentation to Test Attentional Blink for Nontargets

    Published on: December 5, 2014

    9.1K
    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    11.7K

    Related Experiment Videos

    Last Updated: May 24, 2025

    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    18.4K
    A Dual Task Procedure Combined with Rapid Serial Visual Presentation to Test Attentional Blink for Nontargets
    08:45

    A Dual Task Procedure Combined with Rapid Serial Visual Presentation to Test Attentional Blink for Nontargets

    Published on: December 5, 2014

    9.1K
    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    11.7K

    Area of Science:

    • Computational chemistry
    • Bioinformatics
    • Machine learning

    Background:

    • Drug repositioning relies on accurate drug-target interaction (DTI) prediction.
    • Experimental DTI identification is costly and time-consuming.
    • Deep learning models show promise but struggle with capturing local interactions and filtering redundant features.

    Purpose of the Study:

    • To develop a novel deep learning approach, DSANIB, for predicting drug-target interactions.
    • To address challenges in capturing higher-order substructure embeddings and obtaining discriminative representations.

    Main Methods:

    • DSANIB utilizes a Drug-Target Specific Attention Network (DSAN) component with Inter-view and Intra-view Attention Modules.
    • The Information Bottleneck (IB) strategy is employed to retain relevant information and minimize redundancy.
    • The model learns higher-order substructure embeddings for drugs and targets.

    Main Results:

    • DSANIB demonstrated superior performance compared to state-of-the-art (SOTA) prediction models.
    • The approach effectively captures local drug-target interactions and learns discriminative embeddings.
    • Visualization of learned embeddings provided interpretable insights into prediction outcomes.

    Conclusions:

    • DSANIB offers an effective deep learning framework for DTI prediction.
    • The model's ability to learn discriminative representations enhances drug repositioning strategies.
    • The approach provides interpretable insights, aiding in understanding prediction mechanisms.